Hendrik Falk

Statistics

Publications

Citations

1.2K

H-Index

Active since

2011

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Monash University

Commonwealth Scientific and Industrial Research Organisation

Peter MacCallum Cancer Centre

Hendrik Falk is an author at Walter and Eliza Hall Institute of Medical Research specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2011–2023

Publications

Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth

Jonathan B. Baell, David J. Leaver, S.J. Hermans et al. · Nature · 2018 · 314 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +14

HBO1 is required for the maintenance of leukaemia stem cells

Laura MacPherson, Juliana Anokye, Miriam M. Yeung et al. · Nature · 2019 · 174 citations · Full text

Life Sciences, Cell Biology, Hematology +11

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production

Ueli Nachbur, Che A. Stafford, Aleksandra Bankovacki et al. · Nature Communications · 2015 · 152 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

Shatha AbuHammad, Carleen Cullinane, Claire Martin et al. · Proceedings of the National Academy of Sciences · 2019 · 124 citations · Full text

Medicine, Molecular Biology, Oncology +17

PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening

Jonathan B. Baell, Lori Ferrins, Hendrik Falk et al. · Australian Journal of Chemistry · 2013 · 86 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

1–5 of 13